1. Home
  2. AHH vs MNPR Comparison

AHH vs MNPR Comparison

Compare AHH & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armada Hoffler Properties Inc.

AHH

Armada Hoffler Properties Inc.

HOLD

Current Price

$6.77

Market Cap

533.8M

Sector

Finance

ML Signal

HOLD

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

HOLD

Current Price

$69.70

Market Cap

531.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AHH
MNPR
Founded
1979
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
533.8M
531.6M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
AHH
MNPR
Price
$6.77
$69.70
Analyst Decision
Buy
Strong Buy
Analyst Count
4
13
Target Price
$8.13
$97.83
AVG Volume (30 Days)
1.1M
186.6K
Earning Date
11-03-2025
11-13-2025
Dividend Yield
12.15%
N/A
EPS Growth
N/A
N/A
EPS
0.19
N/A
Revenue
$452,636,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.68
N/A
P/E Ratio
$35.75
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.01
$21.00
52 Week High
$10.55
$105.00

Technical Indicators

Market Signals
Indicator
AHH
MNPR
Relative Strength Index (RSI) 53.77 38.47
Support Level $6.90 $64.25
Resistance Level $7.13 $77.45
Average True Range (ATR) 0.15 5.24
MACD 0.03 -1.31
Stochastic Oscillator 48.94 24.95

Price Performance

Historical Comparison
AHH
MNPR

About AHH Armada Hoffler Properties Inc.

Armada Hoffler Properties Inc is a real estate company. It engages in developing, building, owning and managing the high-quality, institutional-grade office, retail, and multifamily properties in various markets throughout the Mid-Atlantic and Southeastern United States. It lease its properties under operating leases and recognize base rents. It also recognize revenue from tenant recoveries, through which tenants reimburses the company for expenses paid by them such as utilities, janitorial, repairs and maintenance. The company's operating segment includes office real estate, retail real estate, multifamily residential real estate, and general contracting, real estate financing and real estate services. It generates maximum revenue from the retail real estate segment.

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Share on Social Networks: